Retour sur lavenir.net
   DEME GROUP 169.000 € (+0,12 %)     CELYAD ONCOLOGY 0.250 € (-9,42 %)     WDP 22.400 € (+1,36 %)     AB INBEV 72.520 € (+1,45 %)     VGP 82.700 € (+1,97 %)     FAGRON 23.700 € (-0,63 %)     ENERGYVISION 14.840 € (+0,27 %)     XIOR 27.950 € (0,00 %)     NYXOAH 1.368 € (-1,16 %)     ELIA GROUP 139.800 € (+1,60 %)     TESSENDERLO 20.900 € (+1,95 %)     KBC 122.650 € (+0,25 %)     BPOST 1.560 € (-0,64 %)     ORANGE BELGIUM 21.800 € (+0,46 %)     ECONOCOM GROUP 1.465 € (0,00 %)     COLRUYT 38.120 € (+0,47 %)     ONTEX GROUP 2.265 € (+2,49 %)     CFE 11.500 € (+0,44 %)     IBA 16.680 € (-0,36 %)     VIOHALCO 17.680 € (+2,67 %)     TEXAF 40.400 € (-2,42 %)     SHURGARD 25.550 € (+1,39 %)     KBC ANCORA 87.100 € (-0,11 %)     UCB 243.300 € (-0,25 %)     FLUXYS BELGIUM D 20.000 € (+2,56 %)     TINC 11.340 € (+1,80 %)     CIE BOIS SAUVAGE 310.000 € (+2,99 %)     SOLVAC NOM(RETAIL) 77.500 € (+3,33 %)     PROXIMUS 6.135 € (+1,24 %)     SOLVAY 26.140 € (+0,62 %)     ONWARD MEDICAL 2.475 € (-0,40 %)     AGFA-GEVAERT 0.400 € (+1,39 %)     GBL 77.850 € (+0,84 %)     ACKERMANS V.HAAREN 269.800 € (+0,45 %)     JENSEN-GROUP 85.800 € (+1,90 %)     SIPEF 93.900 € (+1,62 %)     VAN DE VELDE 30.100 € (+1,69 %)     HOME INVEST BE. 19.860 € (+2,06 %)     CENERGY 21.560 € (+1,41 %)     AGEAS 72.050 € (+1,77 %)     BELYSSE GROUP 0.510 € (+6,25 %)     TUBIZE-FIN 210.000 € (+0,48 %)     BREDERODE 103.000 € (0,00 %)     WERELDHAVE BELGIUM 53.200 € (+1,53 %)     VASTNED 29.400 € (+0,34 %)     ARGENX SE 758.400 € (-0,24 %)     RECTICEL 12.120 € (+0,83 %)     AEDIFICA 70.400 € (+0,72 %)     ASCENCIO 51.600 € (+0,19 %)     CAMPINE 207.000 € (+0,49 %)     AZELIS GROUP 10.480 € (-0,29 %)     GIMV 44.850 € (+0,67 %)     D'IETEREN GROUP 176.000 € (+2,09 %)     BARCO 8.000 € (+2,63 %)     DECEUNINCK 2.190 € (+0,69 %)     RETAIL ESTATES 68.500 € (+1,33 %)     EVS 27.000 € (+0,37 %)     SYENSQO 69.700 € (+0,58 %)     UMICORE 20.280 € (+1,60 %)     CARE PROPERTY INV. 12.680 € (+0,32 %)  
   SAFRAN 327.300 € (+1,36 %)     BNP PARIBAS ACT.A 106.780 € (+1,54 %)     PLANISWARE 20.050 € (+0,25 %)     PROSUS 37.110 € (-3,60 %)     CRCAM MORBIHAN CCI 110.000 € (-0,09 %)     ENGIE 27.560 € (+1,96 %)     SOCIETE GENERALE 78.060 € (+1,11 %)     ALFEN 13.550 € (-1,38 %)     BE SEMICONDUCTOR 248.100 € (+3,59 %)     TIKEHAU CAPITAL 17.300 € (-0,35 %)     ARTMARKET COM 2.600 € (+11,11 %)     PERNOD RICARD 63.140 € (+0,86 %)     EXOSENS 61.950 € (+2,57 %)     EUROPLASMA 0.001 € (-16,67 %)     SCHNEIDER ELECTRIC 269.000 € (+0,07 %)     ABIONYX PHARMA 1.920 € (+3,00 %)     AIR LIQUIDE 176.740 € (+0,12 %)     STELLANTIS NV 5.092 € (+0,20 %)     STMICROELECTRONICS 58.270 € (+1,78 %)     GRAINES VOLTZ 18.000 € (-0,83 %)     ASM INTERNATIONAL 895.400 € (-0,80 %)     GROUPE OKWIND 0.215 € (-10,42 %)     CROSSJECT 1.544 € (-2,03 %)     MICHELIN 35.010 € (-0,14 %)     ACCOR 46.290 € (-0,15 %)     ASML HOLDING 1 589.600 € (-0,24 %)     WOLTERS KLUWER 59.980 € (-0,03 %)     CARREFOUR 16.650 € (+0,63 %)     TOTALENERGIES 74.290 € (+2,03 %)     ING GROEP N.V. 29.215 € (+0,53 %)     ELIS 25.400 € (+0,79 %)     CVC CAPITAL 14.300 € (-0,83 %)     ADYEN 820.900 € (+0,04 %)     AKZO NOBEL 58.140 € (+1,71 %)     LVMH 474.000 € (-0,95 %)     AIRBUS 208.300 € (+7,04 %)     HERMES INTL 1 679.500 € (-0,09 %)     REXEL 38.210 € (+0,26 %)     LARGO 1.520 € (+4,11 %)     UNILEVER 54.090 € (+1,22 %)     KERING 250.750 € (-0,08 %)     CHRISTIAN DIOR 440.000 € (0,00 %)     RELX 28.880 € (-0,07 %)     RAPID NUTRITION 4.070 € (+13,69 %)     ABIVAX 115.400 € (-1,79 %)     BUREAU VERITAS 27.220 € (+0,59 %)     JCDECAUX 22.140 € (+1,28 %)     L'OREAL 380.650 € (+0,50 %)     FUGRO 9.785 € (+1,19 %)     TELEPERFORMANCE 54.260 € (+1,76 %)     QUADIENT 12.880 € (+0,94 %)     AEGON 8.074 € (+0,67 %)     GTT 192.000 € (+1,27 %)     VALEO 13.310 € (+2,11 %)     AMUNDI 87.900 € (-1,18 %)     DASSAULT SYSTEMES 17.760 € (-0,89 %)     FRANCAISE ENERGIE 27.150 € (-6,38 %)     MAGNUM 15.884 € (+0,43 %)     WORLDLINE 10.050 € (-1,08 %)     ARVERNE GROUP 8.960 € (-0,44 %)  
LHYFE
LHYFE - FR0014009YQ1 - Euronext Paris
1,938 €  17:35
+0,52 %
13/07/2026 07:30

Lhyfe and global industrial gases company Messer reach a major milestone: 10-year contract and 30% equity entry by Messer into four renewable hydrogen production sites

A structuring commercial, industrial and financial agreement that strengthens Lhyfe's revenue visibility and consolidates its position among the key players in the renewable hydrogen sector

Nantes (France), Bad Soden (Germany), 13 July 2026, 7:30 am – Lhyfe (EURONEXT: LHYFE) – one of the world's pioneers in the production of green and renewable hydrogen for the decarbonisation of industry and mobility – announces the signing of a major commercial, industrial and financial partnership with Messer, the world's largest privately-owned specialist in industrial, medical, electronic and specialty gases. Messer is taking a 30 percent stake in four of Lhyfe's hydrogen production sites in France and Germany. Moreover, the two partners will sign a 10-year-contract on the supply of renewable hydrogen.

With that single transaction, Messer will be for Lhyfe not only a long-term customer, but also a reference industrial partner and an investor in the assets' equity. It gives concrete form to the priorities announced by Lhyfe — commercial growth through indirect sales, revenue visibility and the demonstration of value created by its portfolio of sites — and marks Lhyfe's first capital rotation. The partnership brings together two highly complementary organizations. Messer contributes decades of expertise in hydrogen technologies, applications, logistics and gas distribution, while Lhyfe has established itself as a leading developer and operator of renewable hydrogen production assets.

A structuring partnership built around three levers

The 10-year supply agreement is backed by three of Lhyfe's sites in France and one in Germany. Messer commits to a minimum volume starting in 2026, which is expected to gradually increase and reach several hundred tonnes per year. Beyond this commitment, Messer aims to purchase half of the output of the three French sites concerned. By becoming a 30% shareholder in the company holding these four sites, Messer validates their industrial quality, commercial positioning and the value-creation potential of the assets developed by Lhyfe. Messer will bring its expertise in industrial gases, particularly in safety, operations, logistics, gas handling, customer relations and multi-gas distribution. This partnership is expected to contribute to the performance, resilience and commercial ramp-up of the sites concerned.

Through this agreement, Messer secures long-term access to renewable hydrogen, including RFNBO-certified hydrogen, sourced from multiple production sites in France and Germany. By integrating this hydrogen into its multi-gas offering, Messer will be able to meet the decarbonization needs of both its existing industrial customers and new clients.

Beyond its commercial dimension, this partnership reflects a convergent view of the renewable hydrogen market between Lhyfe and Messer, including regarding its development potential over the medium to long term.

For Lhyfe: a partnership that strengthens the Group's financial profile.

This partnership strengthens the financial profile through more visible and recurring cash flows resulting from the long-term contract and the minimum purchase commitment as well as a strengthening of the Group's financial position through the sale of a 30% stake in the company holding the four production sites. Lhyfe will continue to consolidate this company on a full consolidation basis and strengthen capacity to focus resources on the most advanced, commercially secured and value-creating projects.

With this transaction, Lhyfe takes a further step in its model as a developer and operator of renewable hydrogen assets. Having completed the permitting, financing, construction and commissioning phases, the Group demonstrates its ability to crystallize the value of its assets through a first capital rotation, while retaining majority exposure to their growth potential and remaining the exclusive operator of these sites — as such, operation and management services continue to be invoiced by Lhyfe to the companies holding these assets.

Completion of the transaction is expected in the coming months and remains subject to lenders' consent, in accordance with in-place financing documentation.

Peter Mohnen, CEO Messer SE & Co. KGaA:

“This agreement marks a major milestone for Messer and Lhyfe and underlines our long-term commitment to enabling the hydrogen economy. By securing access to substantial volumes of renewable hydrogen, we are strengthening our ability to support the decarbonisation ambitions of our customers and prospective customers across a wide range of industries. Demand for renewable hydrogen continues to increase, and the geographically diversified production footprint of these sites allows us to optimize supply chains, shorten transport distances and reduce transport-related emissions. At Messer, we see it as our responsibility to actively contribute to addressing the challenges of our time, and this partnership is an important step toward building a more resilient, competitive and decarbonised industrial future.”

Matthieu Guesné, founder and CEO of Lhyfe:

”The decision of a worldwide leading industrial gases company such as Messer, with more than over 125 years of experience, to join us sends a strong signal to the entire industry. It confirms both the strength of our business model and the accelerating adoption of renewable hydrogen across industrial sectors. Together with Messer, already a Lhyfe customer for several years, we share the conviction that renewable hydrogen is set to become one of the cornerstones of the new industrial energy mix. This agreement gives us the means to strengthen Lhyfe's financial solidity, to pursue our ambition and to develop increasingly transformative and large-scale projects, helping to accelerate Europe's decarbonisation."


About Messer

Messer is the world's largest privately held specialist for industrial, medical, electronic, and specialty gases. Under the brand name ‘Messer – Gases for Life', the company offers gases, services and technology in Asia, Europe, and America. More than 12,000 employees collaborate worldwide based on trust and mutual respect.

'Gases for Life' are indispensable in most industrial processes and help to meet the important requirements of our time. With customized gas solutions, Messer ensures greater safety, sustainability, efficiency, progress, and quality for its customers. Clean hydrogen, carbon capture and storage (CCUS), and Oxyfuel technology play a significant role in the decarbonization of industry and mobility.

Messer offers one of the largest product portfolios on the market and develops patented application technologies for gases in state-of-the-art competence centers. Messer's ‘Gases for Life' are used in industry, environmental and climate protection, the food industry, the electronics industry, in the aerospace industry, welding and cutting technology, additive manufacturing, construction, for new energy, new materials and research and science. As a pharmaceutical company, Messer is a supplier of medical and pharmaceutical gases and complete solutions, proving itself a reliable partner for essential products.

The company was founded in 1898 and is majority-owned by the Messer family.

In 2025, Messer generated consolidated sales of approximately € 4.5 billion.


About Lhyfe

Lhyfe is a European group devoted to energy transition, and a producer and supplier of green and renewable hydrogen. Through its production sites and portfolio of projects, it seeks to provide access to green and renewable hydrogen in industrial quantities, fostering a virtuous energy model that both decarbonises entire sectors of industry and transport and enhances regional energy sovereignty.

In 2021, Lhyfe inaugurated the first industrial-scale green hydrogen production plant in the world to be interconnected with a wind farm. In 2022, it inaugurated the first offshore green hydrogen production pilot platform in the world. Since then, Lhyfe has installed four other production sites and has several sites under construction or extension across Europe. In September 2025, Lhyfe became Europe's largest producer of bulk RFNBO hydrogen from the electrolysis of water.

Lhyfe is represented in 11 European countries and had 188 staff at the end of December 2025. The company is listed on the Euronext market in Paris (ISIN: FR0014009YQ1 – LHYFE).

More information at Lhyfe.com

Click to access the Lhyfe Media Kit (press releases and visuals)


 
Contacts:

Lhyfe:
Industry Press Relations
Nouvelle Graines
Clémence Rebours
+33 (0)6 60 57 76 43
c.rebours@nouvelles-graines.com
Financial Press Relations
ACTUS
Manon Clairet
+33 (0)1 53 67 36 73
mclairet@actus.fr
Investor Relations
LHYFE
Yoann Nguyen
investors@lhyfe.com


Receive by email the next press releases of the company by registering on www.actusnews.com, it's free

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière